Nanometer biological robot and application thereof

A robot and nanotechnology, applied in the new field of nanobiology, can solve the problems of vascular intima injury, small blood vessel embolism, and limited application
CN101744645AInactive Publication Date: 2010-06-23INSITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES +1
1 Cites 20 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
INSITUTE OF BIOPHYSICS CHINESE ACADEMY OF SCIENCES
Publication Date
2010-06-23
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention relates to a nanometer biological robot. The nanometer robot is driven by molecular motors and guided by thrombus antibodies to assist in quickly dissolving thrombi. The rapid rotation of the molecular motors on partial thrombi produces the effect similar to that of a micro power agitator. The molecular motors are driven by light, so the nanometer biological robot is adjustable and controllable. The contact of drugs with fiber proteins is accelerated, the biological and machinery mechanics effect of the nanometer biological robot is synergetic with the medical enzymolysis, and the fibrinolysis is accelerated.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the field of nano-biological new technology, and relates to the design, assembly and application of a light-driven nano-robot constructed by a rotary ATP motor and in assisting drug diffusion (thrombolysis). Background technique

[0002] Traditional thrombolytic therapy methods include drug thrombolysis and device-assisted thrombolysis. In the rescue treatment of acute myocardial infarction, thrombolytic therapy is an effective method to quickly restore myocardial blood flow, and early use of thrombolytic therapy can reduce the mortality rate of patients with acute myocardial infarction by 30% [FEBS.Lett.2005, 579 (15 ): 3303-3309]. Recombinant tissue plasminogen activator (rt-PA) is currently the most effective thrombolytic drug. The main advantage of this drug is that it has a high affinity with fibrin and fast thrombolytic speed; the disadvantage is that it is easily cleared by the liver. , short half-life (4 minutes to 5 ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More